University of Connecticut

OpenCommons@UConn
UCHC Graduate School Masters Theses 2003 2010

University of Connecticut Health Center Graduate
School

June 2000

Characteristics of Adults Seeking Treatment for
Cannabis Dependence: Findings From the
Marijuana Treatment Project
Janice Anne Vendetti

Follow this and additional works at: https://opencommons.uconn.edu/uchcgs_masters
Recommended Citation
Vendetti, Janice Anne, "Characteristics of Adults Seeking Treatment for Cannabis Dependence: Findings From the Marijuana
Treatment Project" (2000). UCHC Graduate School Masters Theses 2003 - 2010. 120.
https://opencommons.uconn.edu/uchcgs_masters/120

CHARACTERISTICS OF ADULTS SEEKING TREATMENT
FOR CANNABIS DEPENDENCE:
FINDINGS FROM THE MARIJUANA TREATMENT PROJECT

Janice Anne Vendetti

B.A., Merrimack College, 1992

A Thesis
Submitted in Partial Fulfillment of the

Requirements for the Degree of

Master of Public Health
at the

University of Connecticut
2000

APPROVAL PAGE

Master of Public Health Thesis

CHARACTERISTICS OF ADULTS SEEKING TREATMENT
FOR CANNABIS DEPENDENCE:

FINDINGS FROM THE MARIJUANA TREATMENT PROJECT

Presented by
Janice Anne Vendetti, B.A.

Major Advisor

han,
Associate Advisor
Bonnie G.

Mliee ,M-..I:I

Associate Advisor

A.

Sten

University of Connecticut
2000

ii

/

ACKNOWLEDGEMENTS

There have been may people involved in the process of completing this
thesis to whom I wish to express my appreciation and gratitude for their

support, contribution and encouragement.

I wish to thank Joseph Sheehan, for his valuable and sincere advice
and heartfelt kindness as my major advisor. I am also grateful to Bonnie

McRee and Karen Steinberg, my associate advisors, for their consummate
guidance and direction as this work developed. Throughout the many
iterations of this thesis, they have thoughtfully offered compassionate
criticism and support. In particular, I thank Bonnie for truly "being there"

for me throughout this often-frustrating process.

The Marijuana Treatment Project Research Group, with whom I have

worked, for the past four years, was generous in allowing me the use of the
project’s data for these analyses. As a whole, this team has been wonderful
to work with and the encouragement and motivation they provided have been
gracious. The MTP Research Group includes Thomas Babor, Bonnie McRee,

Karen Steinberg, Jean Donaldson, James Herrell, Kathleen Carroll, Roger

Roffman, Robert Stephens, Michael Miller, Ken Christiansen, Ronald Kadden,
and Mark Litt.

I would also like to thank Fran Del Boca on whom I called for reality
checks. Her candid advice was reassuring and helped keep me focused.

I am especially grateful to my mother and father, brothers and sisters,
as well as Mr. Kachina and Cody for their unconditional love, warm care, and

persistent questioning about when I would be finished.

iii

Lastly, throughout my many years in the Graduate program, I have
become a faithful fan of the University of Connecticut Women’s Basketball
team. I would like to thank the players and coaches for the many exciting

games in those years, which served as a healthy diversion from my studies.
Their achievements, particularly the 1995 and 2000 National Championships

been an inspiration and reason for remaining a student.

iv

TABLE OF CONTENTS

Io

Purpose and Introduction

1

Background
2.1. Description of Marijuana
2.2. Epidemiology

2
2
3
5
7

2.3.
2.4.
2.5.

Clinical Research
Cannabis Dependence Syndrome
Characteristics of Marijuana-Dependent TreatmentSeeking Individuals

Methodology
3. i. Description of the Marijuana Treatment Project
3.2. Study Design
3.3. Subject Recruitment
3.4.
3.5.
3.6.

Inclusion and Exclusion Criteria
Baseline (Intake) Assessments

Data Analysis

Results
4.1. Characteristics of Eligible Individuals
4.2. Characteristics of Eligible Individuals Who Declined
Participation (DP)vs. MTP Participants
4.3. Characteristics of MTP Participants
4.3a. Demographic Characteristics
4.3b. Marijuana Use and Treatment History
4.3c. Dependence Criteria
4.3d. Problem Measures
4.3e. Hazardous Use
4.3f. Analyses by Gender, Ethnicity, and Employment
Status

5

Summary and Discussion
5. I. Rationale for Marijuana-Specific Treatment
5.2. Barriers to Treatment Participation
5.3. Consequences of Marijuana Dependence
5.4.
5.5.

Other Severity Indices

Summary

References

10

12
12
13
14
15
16
18

19
19

21
22
22
23
24
24
25
26

29
30
31
33
34
36

............................................................................

37

...........................................................................

42

Appendices

LIST OF TABLES

Table 1

Baseline Assessments

42

Table 2

Demographic Characteristics From the Quick Screen,
Eligible Screened Sample

43

Alcohol and Drug Use Characteristics From the Quick
Screen, Eligible Screened Sample

44

Psychiatric Characteristics From the Quick Screen,
Eligible Screened Sample

45

Demographic Characteristics From the Quick Screen,
Significant Findings; Eligible Screened Sample by Study
Participation

46

Alcohol and Drug Use Characteristics From the Quick
Screen, Significant Findings; Eligible Screened Sample by
Study Participation

47

Table 3

Table 4

Table 5

Table 6

Table 7

Table 8

Table 9

Table I0

Table I I

Table 12

SCID Dependence Symptoms, Percent of MTP Participants
Who Endorsed Each Symptom

48

Marijuana Problem Items, Percent of MTP Participants
Who Endorsed Each Item

49

Hazardous Use (in the past 90 days), Percent of MTP
Participants

50

Treatment and Medication Utilization, and Severity
Measures, Significant Findings; MTP Participants by
Gender

51

Alcohol and Drug Use, Medications, and Severity
Measures, Significant Findings; MTP Participants by
Ethnicity

52

Medical Care and Severity Measures, Significant Findings;

MTP Participants by Employment Status

vi

53

1. Purpose and Introduction.

The purpose of this thesis is to provide a description of the
characteristics of marijuana-dependent treatment-seeking adults through a
review of the literature. In addition, findings from a multi-site clinical

treatment trial for marijuana dependence will be presented. Although

several previous studies have described the characteristics of marijuana

treatment-seeking adults (Budney et al., 1996; Stephens, Roffman, &
Curtain, in press; Stephens, Roffman, & Simpson, 1993), the present study
is the largest of its type and the first to specifically target culturally and

economically diverse individuals, as well as women. A primary aim of this

paper is to examine the characteristics of individuals who were eligible for
the Marijuana Treatment Project and chose not to participate in relation to

the characteristics of those who did participate in the trial. Another goal is
to describe the demographic as well as clinical characteristics of the sample,

including frequency of marijuana use and severity of dependence.
Integration of findings based on the client characteristics in the current
multi-site trial along with those of earlier studies should be helpful in the

development of future relevant and effective treatment programs for primary
marijuana dependence.
Marijuana is the most commonly used illicit substance in the United

States. According to the Summary of Findings from the 1998 National
Household Survey on Drug Abuse, there are 11 million marijuana users who
smoked in the past month (SAMHSA, 1999). Marijuana use is often thought
to be associated with the abuse of other drugs and alcohol. However, several
recent studies have shown that there is a group of individuals who seek

substance abuse treatment with marijuana as their primary drug of abuse.

In the past decade, there has been an increased interest in identifying the

"pure" marijuana user, as well as assessing the need for marijuana specific
treatment (Hall & Babor, in press; Roffman & Barnhart, 1987; Stephens,

Roffman, & Simpson, 1993; Zweben & O’Connell, 1992).

2. Background.

Following is a description of marijuana, a review of the epidemiology
of marijuana use, a review of the available clinical research, and a

description of the Cannabis Dependence syndrome. Finally, data from
several earlier studies describing characteristics of marijuana-dependent

treatment-seeking individuals are reviewed.
2.1. Description of Marijuana. The term marijuana is commonly used
to refer to the smokable part (i.e., the flowering tops and leaves) of the
cannabis plant. Cannabis sativa L., the hemp plant, is the most prevalent
strain in the United States and grows wild throughout the tropical and

temperate regions of the world. Cannabis contains numerous chemicals
called cannabinoids that are unique to the cannabis plant. The most well
known of these cannabinoids, delta-9-tetrahydrocannabinol (THC), is

thought to be responsible for the characteristic psychoactive effects of
cannabis. The THC content of any given strain of illicit marijuana varies. In

the early 1970’s, the average THC concentration was less than 1%. The
current range is from 7% to as much as 17% in sensimilla, the seedless and
most prevalent form of marijuana (Hall, 1995). These higher concentrations

of THC in marijuana may contribute the likelihood that individuals may

become dependent. Though it is most commonly smoked, marijuana can be
consumed by eating or even drinking the cannabis products.
2.2. Epidemiology. After a decline in the number of new users since

1975, the incidence of marijuana use has been on the rise since 1991.
According to recent data from the National Household Survey on Drug

Abuse, there were 2.5 million new users of marijuana in 1996. These data
also show that the age of new users has been getting younger and younger
each year. That is, in 1996 the annual age-specific rate of first use per

1,000 person-years of exposure was 83.2. In 1993 it was 53.9, the highest it
had been for 10 years. In addition, the mean age of onset has steadily

decreased from 19 years old to 16 years old since 1986 (SAMHSA, 1998).

Nationally, marijuana is the most common non-prescription drug being used

today and accounts for 81% of all illicit drug use. Of the almost 14 million
illicit drug users surveyed, 81% used marijuana. The majority of these,

(60%) used marijuana exclusively, while 21% combined their marijuana use
with some other drug

(SAMHSA, 1999).

When comparing data from the state of Connecticut to national data,
the statistics on marijuana use are similar. Marijuana is also the most

commonly used illicit drug in the state of Connecticut. Approximately one in
three Connecticut residents have tried marijuana at least once in his or her

life, and approximately 3% reported use in the past month (Ungemack et al.,

1999).
National and state drug abuse surveys provide information about use

patterns including the more severe pattern of dependence characterized by a
chronic pattern of use associated with psychological, physiological, and
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social problems related to marijuana use. In the 1996 Adult Household

Survey of Connecticut, 3.9% of 18-25 year olds met the criteria for current
Cannabis Dependence, the national equivalent was slightly higher at 4.9%.

For 26-34 year olds, 1.2% of Connecticut residents was currently dependent
on marijuana, whereas 1.6% was reported nationally. For those who were

35 years or older 0.1% reported current dependence in Connecticut versus
0.3% nationally (Ungemack et al., 1999).

Despite these rates, treatment for marijuana dependence is not being

sought at the same rate. Findings from the National Treatment

Improvement Evaluation Study found that most marijuana users in drug
treatment are there for cocaine and alcohol dependence, whereas marijuana-

only users represent just 6% of those in treatment (Wisdom, 1999).
Connecticut state data are consistent with national data. Only 3% of
individuals presenting for substance abuse treatment identified marijuana
as their primary drug of abuse (Ungemack, Laube,

& Babor, 1995).

However, because of differences in sampling frames surveys,
measures of treatment use and need can vary greatly. General population

research can be inadequate in covering crucial population groups residing
within the sampled areas. For instance, individuals living in jails,

residential treatment facilities, university and military housing,

convalescence or elderly homes, in addition to homeless populations

represent an increasing percentage of the United States population not being

surveyed for treatment need. In addition, alcohol and drug abuse tend to be
widespread with these individuals (Schmidt & Weisner, 1999).

2.3. Clinical Research. Despite the prevalence of chronic marijuana
use described in epidemiological data sets, there is relatively little systematic

understanding about the characteristics of dependent individuals and the

pattern of problems experienced by these individuals. While individuals who
use marijuana infrequently may resemble the occasional drinker, and not

experience problems related to its use, users who cascade into dependence

may indeed suffer a constellation of negative consequences as a result of
their smoking behavior (Hall & Babor, in press; Stephens & Roffman, 1996).

There are a number of plausible explanations for the lack of research
in this area. One is the common perception that marijuana is a benign drug

and chronic use does not pose a health threat. Another rationale for the
lack of empirical studies stems the common misconception that marijuana

does not produce physiological dependence, and the consequences of its use
are not as threatening as alcohol or other psychoactive drugs. To the

contrary, regular users have reported many concerns, among them, cognitive
deficits such as memory and concentration loss, or problems with thinking

(Solowij, 1998). Individuals who consider themselves dependent also report
relationship difficulties with family members and friends. Employment

problems and psychological issues such as lack of self-esteem and
motivation are also among the many cited concerns for users, as are health

problems (Stephens, Roffman, & Simpson, 1993). Marijuana is most often
smoked, which puts the user at greater risk of respiratory diseases.
Cannabis smoke is quantitatively very similar in composition to tobacco

smoke. Thus, it is likely that chronic marijuana use will cause similar lung
diseases such as bronchitis, or cancer (Hall, 1995; Tashkin, 1999). A recent

epidemiological study found evidence that chronic marijuana use may
increase the risk of head and neck cancer with a strong dose-response

pattern (Zhang et al., 1999).
Physiological withdrawal symptoms resulting from marijuana use
were often believed to be of relatively low intensity

(Roffman et al., 1988).

And it was often perceived that if withdrawal symptoms did occur, it was
because of concurrent involvement with other substances. In fact, many

previous studies (Rainone et al., 1987) found it difficult to isolate the heavy
marijuana user who was not concurrently using other drugs. These studies
were unable to separate the polydrug user from those who did manifest a

Cannabis Dependence syndrome independent of other drug or alcohol use

problems. However, recent studies have now begun to document that
individuals may develop both physiological and psychological dependencies
on cannabis, and that cessation from use may produce a withdrawal

syndrome broadly characterized by anxiety, restlessness, sleep disturbance
and appetite change (Budney, Nory, & Hughes, 1999; Jones, Benowitz, &

Herning, 1981; Weisbeck et al., 1996). Although the Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) of the
American Psychiatric Association (1994), states that Cannabis Dependence
is often seen in the absence of tolerance or withdrawal symptoms, this

theory is being challenged by accumulating evidence to suggest a true
physiological withdrawal syndrome exists. Thus, tolerance to cannabisinduced effects can indeed occur (Compton, Dewey, & Martin, 1990; Jones,

Benowitz, & Herning, 1981).

More recent attention to the concept of Cannabis Dependence and
treatment may be due to a number of emerging arguments. Changes in

cultural attitudes toward illicit drug use as well as the social and

physiological side effects of marijuana use (Zweben & O’Connell, 1992) may
be influencing this shift. New workplace policies including drug testing are

creating environments in which marijuana use is not only prohibited but
also monitored. In order to maintain their employment, many marijuana
users who are unable to stop smoking are seeking help from treatment

facilities. In one study designed to assess the need for Cannabis

Dependence treatment, individuals were asked to respond to an
advertisement if they were concerned about their marijuana use.

Investigators found that 92% said that they would be interested in

participating in a treatment program designed specifically for marijuana
users. The study also indicated that only 18.2% of the respondents had ever

been treated for drug abuse in the past, suggesting a fair degree of unmet
treatment needs (Roffman & Barnhart, 1987).

2.4. Cannabis Dependence Syndrome. Despite previous beliefs that

marijuana may not produce a dependence syndrome, there is increasing
evidence to suggest that individuals who exhibit a chronic pattern of use

develop a substance-related disorder characterized by psychological,
physiological, and social problems related to their smoking (Budney, Nory, &

Hughes, 1999; Stephens, Roffman, & Simpson, 1993).
The criteria that comprise the Substance-Related disorders are
described in the Diagnostic and Statistical Manual of Mental Disorders,

Fourth Edition (DSM-IV). The essential features of Substance Dependence

can be applied to each of ten classes of drugs including alcohol,

amphetamines, cannabis, cocaine, hallucinogens, inhalants, nicotine,
opioids, phencyclidine, and sedatives. The syndrome is defined by a
combination of physiological, cognitive, and behavioral symptoms. These

symptoms are indicative of an individual’s continued use despite the

knowledge of significant problems resulting from the substance use.
Dependence can also be exhibited by a pattern of repeated drug use that
results in tolerance, withdrawal, and continued compulsive use.

In a field trial designed to examine cross-system agreement for
substance-use disorders, Rounsaville et al. (1993) investigated diagnoses

based on DSM-III-R, DSM-IV and the latest version of the International
Classification of Diseases (ICD-10). Findings from the study indicated that

heavy marijuana use was not characterized as consistently as other drugs by
the elements of the dependence syndrome. The authors noted that this is
most likely due to the fact that marijuana is not associated with a "rush" of
sensations that would encourage the user to develop compulsive use. Also,

marijuana is usually not associated with the extreme withdrawal symptoms
that are typically the basis for relief use. Thus, the gradual onset of effect
and elimination of THC is not as likely to promote the compulsive behaviors
associated with drugs like cocaine or opioids. Nonetheless, the authors

recommend retaining the identical dependence syndrome criteria for
Cannabis Dependence noting that differences across substances will be

reflected in the number of symptoms endorsed by heavy users.
With these caveats in mind, Cannabis Dependence may be described
as a maladaptive pattern of use, accompanied by significant clinical

impairment or distress as manifested by at least three of the following seven

symptoms coexisting in a 12-month period. (1) Tolerance: Tolerance is
described as the need to smoke more marijuana in order to get high, or

achieve a desired effect. In other words, smoking the usual amount does not

produce the previously desired "high". (2) Withdrawal: The presence of
marijuana-specific withdrawal symptoms (e.g., irritability, agitation, anxiety,
craving, sleep difficulty, headaches, nausea, etc.) as the result of stopping or
cutting down use of marijuana. Withdrawal also may be identified by an
individual’s smoking marijuana in order to avoid or relieve the

uncomfortable symptoms of withdrawal. (3) Compulsion: Marijuana is used
for a longer period of time or in greater amounts than intended. For

example, someone may intend to take only one hit, and end up smoking the
whole joint to the point of severe intoxication. (4)Compulsion is also
demonstrated when the time spent buying marijuana, using marijuana or

recovering from its effects are such that most of the day is taken up by these
activities. (5) Re-addiction Liability: There are often unsuccessful attempts
or persistent desires to quit or cut down.

(6) Salience: Marijuana use takes

up the time (or reduces the time) normally spent on meaningful occupational
activities, recreational activities, or social activities. (7)Salience can also be
exhibited by continued smoking despite a persistent or recurrent

psychological or physical problem that was most likely caused or worsened

by marijuana use (e.g., a nagging cough, or memory loss). This criterion
does not focus on the content or presence of a particular problem or

impairment, but rather the individual’s knowledge that marijuana use and
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the subsequent failure to abstain from smoking cause the problem

(American Psychiatric Association, 1994).
2.5. Characteristics

of Marijuana-Dependent Treatment-Seeking

Individuals. There have been a few studies that have examined the

characteristics of treatment-seeking marijuana-dependent adults. Roffman

and Barnhart (1987) conducted one study that assessed the need for

marijuana specific treatment through a telephone survey. Individuals in this

study were not clinically assessed for dependence, but rather recruited
based on their concern about their chronic marijuana use. They were later
assessed for problems associated with their use and their desire for

marijuana treatment. As a result of the high response rate to the study,

Stephens, Roffman, and Simpson (1993) conducted a follow-up study at the
University of Washington that examined the efficacy of attracting and
intervening with adult marijuana users. Budney et al. (1999) conducted a

study that considered the effectiveness of interventions incorporating
cognitive and contingent reinforcement techniques for marijuana

dependence.
The samples in these studies were found to reflect similar

demographic characteristics. The average participant was 32 years old,
white, and male. The telephone screening procedure versus the treatment

study in Washington showed respectively that 44% and 40% of the
interested participants were married, 38% and 46% were single, and 12%

and 13% were divorced, while Budney’s study showed 50% had never been
married. The level of education attained by the participants varied by study,

however, this may be a function of how the studies were promoted. Only
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50% of Budney’s participants completed some education beyond high

school, whereas the phone screen attracted 91% who had 12 or more years
of education, and the treatment study recruited 78% with at least a high

school education. Although the treatment study did not indicate the

employment status of their participants, the telephone sample and Budney’s
sample attracted mostly employed individuals (79% and 65% respectively).
The largely similar distributions across demographic categories lend support
for a tentative profile of the typical chronic marijuana user.

These studies found that marijuana treatment-seeking individuals

reported a number of adverse psychological, physiological and social
consequences, as a result of chronic use. These consequences included
relationship difficulties with family and friends, legal, employment and
financial problems, health problems, and cognitive impairments. Stephens,

Roffman, and Simpson (1993) found that the most common problem
reported in the sample was the inability to stop smoking (93%). The next
most commonly reported problems were negative feelings about abuse (87%),

procrastination (86%), and a decrease in self-confidence (76%). Memory loss
was a concern for 67% of the sample. Other worries included experiencing

unpleasant withdrawal symptoms (51%), family problems (47%), financial
difficulty (41%), decreased work/school performance (15%), and legal trouble

(3%). Roffman and Barnhart (1987) found that similar problems were of
concern for their participants as well, although in their study, self-reported

cognitive problems ranked highest. Self-esteem, health, family

relationships, and financial problems were next among the most noted
adverse consequences associated with their use of marijuana.

12

Budney’s sample (1999} had been chronic smokers for an average of
15 years and met 6.4 of the 9 dependence criteria (71%) as outlined in DSM-

III-R. They also smoked about four times a day on roughly 75% of the days
in the month prior to intake. Similarly, the treated sample in Washington

(Stephens, Roffman, & Simpson, 1994} found that their sample had been
smoking regularly for 15 years. They smoked marijuana about 2.7 times a

day on 81 of the past 90 days. Consistent with national data, these trials

reported that their participants began smoking regularly at about age 16 or
17 (Budney et al., 1999; Roffman & Barnhart, 1987; Stephens, Roffman, &

Simpson, 1993).

Stephens, Roffman and Curtain (in press) recently conducted a study
comparing extended and brief interventions for marijuana use. The
demographic and marijuana use characteristics are remarkably similar to
the previous treatment study by Stephens, Roffman and Simpson (1994).

3. Methodology.
3.1. Description of the Marijuana Treatment Project. The Marijuana

Treatment Project (MTP), otherwise known as the Multi-site Study of the
Effectiveness of Brief Treatment for Cannabis Dependence, was a three-year,
randomized clinical trial that investigated the effectiveness of brief
interventions for adults with Cannabis Dependence. The project, funded by

the Center for Substance Abuse Treatment (SAMHSA-CSAT) in October of

1996, was a cooperative agreement with three recruitment sites and one
coordinating center. The recruitment sites were located in Farmington, CT,

Miami, FL, and Seattle, WA, with a Coordinating Center also located in
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Farmington, CT. The primary goal of MTP was to compare two brief
treatments for Cannabis-Dependent individuals from differing socioeconomic and racial backgrounds.

The research battery began with a telephone screening interview, and
further in-person, or face-to-face evaluations were carried out at intake into
the study, at the end of treatment, and at 4, 9 and 15 months post
randomization.

3.2. Study Design. Although the primary goal of the Marijuana

Treatment Project was to evaluate treatment effectiveness, the purpose of
this study was to describe the characteristics of the marijuana-dependent

treatment-seeking adults who were randomized into the Marijuana

Treatment Project. In addition, those who were eligible for the study, but
who declined participation, were examined in relation to trial participants.

Telephone screening and intake data were utilized to examine the
hypothesis that there is a distinct group of treatment-seeking adults who are

dependent solely on marijuana. More specifically, these individuals vary in
gender, ethnicity, and employment status although other studies (Budney et
al., 1996; Stephens, Roffman, & Curtin, in press; Stephens, Roffman, &
Simpson, 1994) have suggested that marijuana treatment seekers tend to be
primarily Caucasian, male, and employed. Subjects were classified from the
screening data according to study participation. Eligible study participants
who volunteered for the MTP were compared to eligible subjects who
declined study participation and treatment. These groups were compared on
a variety of measures including demographic information, marijuana use

history and alcohol and other drug use. Further examination of the final
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MTP sample including analyses by gender, ethnicity, and employment status
was done to provide data relevant to the implementation of treatment

programs and to address access needs of individuals seeking treatment.
3.3. Subject Recruitment. Recruitment for the Marijuana Treatment

Project took place between May of 1997 and August of 1998, primarily

through media advertisements. The ads targeted adults who were interested
in receiving free treatment to help them quit or reduce their heavy marijuana
use.

A telephone screening questionnaire (the Quick Screen) was
administered to interested subjects to determine preliminary eligibility for

the study. If a participant appeared to meet the inclusion criteria, a baseline
interview was scheduled in-person to review the eligibility criteria and
determine the participant’s appropriateness for the study. If deemed

appropriate (i.e., met the inclusion criteria, willing to accept randomization,
and interested in participating), the subject was asked to sign an informed
consent form and complete the baseline assessment battery.

A total of 1,211 interested callers were screened over the telephone
during the sixteen-month recruitment period. The three treatment sites
collectively recruited 450 eligible participants for the trial (Farmington, CT
recruited 155, Seattle, WA recruited 146, and Miami, FL recruited 149), and
elicited a final subject pool of 308 men and 142 women. Of the remaining

761 screened, 398 were ineligible, while 363 individuals were eligible at the
time of the screening but declined the opportunity to participate or did not

attend the face-to-face baseline interview.
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3.4. Inclusion and Exclusion Criteria. Potential participants for the

MTP were required to meet certain criteria for inclusion in the study.
Individuals had to be at least 18 years old to participate. They had to have

smoked marijuana on at least 40 of the 90 days prior to the interview, and

had to meet the diagnosis of current Cannabis Dependence as described in
the DSM-IV. Those who were currently dependent on another drug or

alcohol, as defined in the DSM-IV were excluded as were those who
indicated a need for immediate treatment that would not allow for
randomization into the delayed-treatment control group. Acute medical or

psychiatric problems were exclusionary criteria as they might interfere with
the MTP treatment. Those who were currently receiving treatment for a drug
or alcohol problem or regularly attending a 12-step fellowship program were

also excluded from the study. Finally, individuals were not eligible to

participate in MTP if the legal system had mandated drug treatment or urine
screening as part of their sentencing or probation.
Certain logistical variables were also examined to ensure that

participation in the treatment and research protocol would not be
compromised. Subjects were required to have access to reliable
transportation and live within 60 miles of the treatment clinic. In addition,
potential subjects could not be planning to move in the near future.

Participants were excluded if they could not identify a locator to assist in

follow-up tracking. Additionally, individuals were required to understand
English well enough to participate meaningfully in the treatment, although

they were not excluded for the inability to read or write in English.
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3.5. Baseline (Intake) Assessments. The initial appointment for the

participant was a two-part assessment designed to elicit objective data, as
well as self-report information. It was comprised of two components; a

diagnostic component designed to review the eligibility criteria and a pretreatment component for those who were seen as eligible for the study.

Interviewer-administered assessments and self-report questionnaires were
utilized as the primary methods of obtaining intake data.

Table 1 outlines the assessments administered to MTP participants
that were utilized for this paper. Both the alcohol and drug modules of the

Structured Clinical Interview for DSM-IV, also known as the SCID (First et

al., 1996) was used to further determine an individual’s eligibility for the

MTP. This interview assesses each of the seven dependence criteria for
drugs, including sedatives, stimulants, opiates, cocaine, hallucinogens,
inhalants and cannabis, as well as alcohol. Individuals were required to

meet the diagnosis of Cannabis Dependence. In addition, the SCID was

used to indicate whether a participant met the criteria for dependence on

alcohol or other drugs which would make them ineligible for the study.
Three additional instruments comprised the pre-treatment component
of the baseline evaluation. These included the Addiction Severity Index

(McLellan et al., 1992) the Time Line Follow-Back interview (Sobell & Sobell,
1992), and a short treatment services utilization questionnaire. The
Addiction Severity Index (ASI) was used to collect information about
circumstances in the subject’s life which may have had an impact on, or be

affected by, their substance abuse problem. The major areas of assessment
included severity indices of the participant’s alcohol and drug use status,
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medical status, employment and support status, legal status, social

relationships and psychiatric status.
The Time Line Follow-Back (TLFB) is an instrument originally

designed to aid research participants in the recall of their daily drinking
routine. The structure of this interview was modified to accommodate a

marijuana use pattern instead. The TLFB adapted for the Marijuana

Treatment Project was used to assess the participant’s marijuana use by
employing calendar prompts for a specific time frame (i.e., the last 90 days).
The interviewer and the participant worked together to evaluate the pattern
of smoking by the participant. This was done by completing a calendar, first
with key dates, idiosyncratic events, weekly events, holidays, or special

events which my have helped the individual in remembering his or her

marijuana use pattern. Then the participant was asked to recall marijuana
use with regard to specific quadrants of the day. That is, whether or not the

participant smoked in the morning, afternoon, evening or nighttime. In
addition to how often individuals smoked, participants were also asked to

remember whether or not they used alcohol or other drugs on those days.

Once the calendar portion of this instrument was completed, the
participants were also asked questions about their use of marijuana in
hazardous situations (e.g., while driving a car or taking care of children).

A short treatment services utilization questionnaire was used to
evaluate subjects’ use of general medical, drug and alcohol treatment, and

psychiatric services, both inpatient and outpatient in the past 90 days. In
addition, medication use was recorded as were other social services utilized
in the last 90 days.
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Participants were also asked to complete a battery of self-report
questionnaires. These included: 1) The Beck Depression Inventory (Beck et

al., 1961). The BDI includes 21 symptoms and attitudes that are common
among depressed psychiatric patients. These items are rated on a scale of 03 in intensity and summed. The higher the score, the more severe the level

of depression in the patient. 2) The State-Trait Anxiety Inventory (State)

(Spielberger et al., 1983). The STAI-State is a measure of anxiety that is
used to assess current emotional experience. Each of the 20 items is based
on a weighted 4-point scale ("almost never" to "almost always"), resulting in
a range from 20

(low anxiety) to 80 (high anxiety). 3) The Marijuana

Problem Scale (Stephens et al., 1994). The MPS was designed to include
recent (i.e., last 90 days) problems associated with cannabis use. The 19
items are rated by the participant as "not a problem", as a "minor problem",
or as a "major problem". For MTP research purposes, the number of

problems endorsed (whether a minor or major problem) were simply summed
for a range of 0-19. A number of additional self-report assessments were
administered at the baseline interview for the MTP, but were not used in

these analyses.
3.6. Data Analysis. The data were collected and entered on site using

SPSS Data Entry. Each assessment was entered and then verified before
being sent to the centralized coordinating center where the data from all
three sites were merged. The data were then checked for logical

inconsistencies, anomalies, and missing values. Pearson chi-square tests of
independence were used to determine the significance of association
between categorical variables. Independent-Samples T Tests were used to
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test difference among the means of two-group samples while One-Way

Analysis of Variance (ANOVA)was used to test differences among the means
of the three-group samples. Levene’s test for homogeneity of variance was
utilized for testing the assumption that the groups’ variances were equal.

When ANOVA tests were significant, LSD post hoc tests were employed to
determine where differences lie. The SPSS default of .05 significance level
was used and missing data were handled on a case by case basis.

4. Results.
4.1. Characteristics

of Eligible Individuals.

Of the 1,211 persons

screened for the Marijuana Treatment Project, this study focuses on the 813
individuals deemed eligible at the time of the telephone screening process.

Of those, 363 (45%) decided not to participate in the project while 450 (55%)
were successfully recruited into the study. This sample describes a group of

individuals who were interested in a treatment program designed specifically

for those who are marijuana dependent. Table 2 shows that these
individuals were primarily male (68%), and on average, 35 years old. Sixtyfive percent of the group was White, while 15.6% was African American and

16.5% was Hispanic. Sixty-five percent of the sample was unmarried, and

approximately half (56%) lived in a rented house or apartment. Individuals
in this group had, on average, 14 years of education. Sixty-four percent

worked full-time, 14% worked part-time, and 16% were unemployed. Those
who did work had been employed at their current job for approximately five
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Drug use data in Table 3 show that marijuana use was the primary
concern for these individuals. Eighty-seven percent felt that they were

currently dependent on marijuana. Only 16% of the sample reported past
dependence on alcohol, while 22% reported past dependence on a drug other
than marijuana. At the time of the screening, almost the entire sample

(99%) felt that marijuana was the biggest problem for them (relative to
alcohol or other substances). The group reported smoking marijuana on 81
of the past 90 days (90% of the days), and smoked an average of 3.8 times a

day. They reported drinking alcohol an average of two drinks per drinking

day, and rarely drank more than 5 drinks in a sitting (.93 days in the past

month). Use of other drugs in the past 30 days was also infrequent,
although it should be noted that current alcohol and other drug dependence
were reasons for exclusion. Sedatives and cocaine were used on average .20

days, opiate use, 11 days, stimulants were used on .04 days, and heroin
was used on .02 days. Use of Methadone or intravenous drugs are not

reported, as both were exclusion criteria.

In order to prevent the study’s findings from being contaminated by
mediating factors, anyone who was receiving psychiatric treatment for
alcohol or other drug problems, including AA meeting attendance at the time
of the study initiation, was excluded from participation. In addition, anyone
who had a chronic psychiatric or medical problem that required

hospitalization was excluded. However, general outpatient psychiatric

counseling was permitted. Table 4 shows that a small proportion (8%) of
those eligible for participation were currently receiving treatment for a

psychiatric problem. Just fewer than 8% had been hospitalized in the past
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for a psychiatric problem, and 6% indicated that they had serious thoughts
of suicide in the past 90 days.

4.2. Characteristics

of Eligible Individuals

Who Declined Participation

(DP) vs. MTP Participants. In an effort to identify potential barriers for
individuals who might benefit from treatment, the 363 individuals who were
considered eligible at the time of the telephone screen but chose not to

participate in the Marijuana Treatment Program were compared to the 450

participants enrolled in the study. Table 5 highlights the demographic
characteristics that were significantly different for the study participation

groups (DP vs. MTP). Treatment participation was shown to be associated
with ethnic group and social stability. Particularly, African American callers
were less likely to participate in the study. Although they were interested in

treatment, many failed to show for their baseline interview or declined
participation in the study (20.2% DP vs. 12.0% MTP;

17.72, p<.01).

Those who were unmarried were more likely to decline participation or not
show for their baseline interview (70.8% DP vs. 59.8% MTP;

10.56,

p<.01). Participants in MTP were more likely to own or live in a family owned
residence (45.8% MTP vs. 36.4% DP; -=7.82, p<.05) and were less likely to

be unemployed (12.4% MTP vs. 21.3% DP;

=19.30, p<.01).

In addition, those who declined participation were, on average, two
years younger than those in the MTP (33.78 DP vs. 36.08 MTP; t=-3.69,

p<.01). The non-participators had fewer years of education (13.30 DP vs.
14.04 MTP; t=--5.03, p<.01), were employed in their current job for fewer

years (4.04 DP vs. 5.03 MTP; t=-2.13, p<.05), and had moved more times in
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the past year (.78 DP vs..47 MTP, t=4.00, p<.01) than those who did

participate.
The decision to participate in the study was associated with the

response to the question "Are you currently dependent on marijuana?"
Table 6 shows that 91.6% of the MTP participants said that they were

currently dependent on marijuana while only 81.4% of the non-participators
indicated that they were dependent ( =22.10, p<.01). Those who decided

not to participate drank more alcohol drinks per drinking day than the MTP

participants (2.29 vs. 1.85 respectively, t=2.94, p<.01). Further, those who
participated in the MTP were less likely to have used sedatives (t

2.20,

p<.05) or cocaine (t=3.02, p<.01) in the past 30 days, suggesting that MTP
attracted a ’purer" marijuana smoking group.
Variables that might normally be assumed to be associated with study

participation but were not were recruitment location, gender, lifetime

dependence on alcohol or other drugs, and lifetime or current psychiatric
problem (including suicidal ideation). Marijuana smoking pattern, including
the number of days smoked in the past 90, the number of times smoked per

day, and the number of days since the last smoking episode were also
similar across the two groups.
4.3. Characteristics

of MTP Participants.

The following sections

examine characteristics from the final randomized sample of the Marijuana

Treatment Project. Because these individuals were enrolled in the study, a
more extensive assessment battery was collected for them.

4.3a. Demographic Characteristics. Thirty-two percent of the final 450

MTP participants were female. Table 5 illustrates those participants enrolled
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in the Marijuana Treatment Project. The three recruitment locations

collectively attracted a diverse sample. Overall, twelve percent of the final

sample were African American and 17% of the sample were Hispanic. The
Seattle, WA site recruited mostly White participants. Eighty-five percent of
their sample was White. Forty-one percent of the Miami, FL sample was

Hispanic, and 20% of the Farmington, CT sample was African American.
The mean age of the study sample was 36 years. The majority of

participants were employed full-time (69%), while 14% were employed parttime, and 17% were unemployed (including students, homemakers, retired

individuals). Those who were working had been employed at their current
job for an average of five years. Sixty percent of the sample were not married
and 52% lived in a rented house or apartment, whereas 46% lived in their
own or a family owned house. The mean number of years of education for

the MTP group was 14.
4.3b. Marijuana Use and Treatment History. MTP participants

reported few lifetime treatment episodes; 82% had never received treatment
for drug abuse and 93% had never received treatment for alcohol abuse.

Intake data from the sample of 450 subjects showed that the MTP

participants smoked marijuana, on average, 80 out of the last 90 days, and
were high, on average, more than 6 and a half hours during a day. They

smoked approximately three standard sized joints per day and used about

three-eighths of an ounce of marijuana per week. The group indicated

having smoked marijuana regularly (i.e., three or more times per week) for
approximately 18 years, and reported that it had caused problems for them
for over nine years.
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4.3c. Dependence Criteria. Because there have been relatively few
clinical studies of chronic marijuana smokers, a goal of the MTP was to

carefully document the reported dependence symptoms through the use of a
structured clinical interview. Of the seven DSM-IV dependence criteria for
Cannabis Dependence, participants in the study were diagnosed, on

average, with 5.6 of the symptoms.
Table 7 lists the DSM-IV criteria for marijuana dependence and the

percentage of individuals who endorsed each criterion as reported on the
SCID. A large proportion of individuals experienced tolerance (68%) and
withdrawal (78%) symptomatology. A substantial majority reported a

compulsion to use marijuana with 77% using in larger amounts or over a

longer period of time than they intended, and 83% spending a great deal of
time getting, using and recovering from the effects of marijuana. In addition,

96% of the sample reported a persistent desire or unsuccessful attempts to

quit, cut down, or control their marijuana use.
While 64% reported that marijuana took up much of the time

normally spent on other activities, almost the entire sample (95%) reported
that they continued using marijuana despite knowing that it caused

persistent or recurrent psychological problems (e.g., excessive sedation,
decreased motivation, depression, anxiety, decreased concentration or

memory problems) or physical problems (e.g., chronic colds, coughs, or

asthma).
4.3d. Problem Measures. The Marijuana Treatment Project employed
a relatively new instrument to assess the number of problems marijuana has

caused the participants. The Marijuana Problem Scale, developed by
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Stephens et al. (1994) was designed to look at specific problems someone
might incur as the result of long-term marijuana use. These problems may
be personal (e.g., memory loss), social (e.g., problems between you and your

partner), or occupational (e.g., to have lower productivity). For this study,
the instrument was used to assess 19 items that may have been considered
a problem within the baseline period.

Table 8 shows the percentage of the sample that endorsed each

problem item as either a minor problem or a major problem. Overall, the

average number of problems endorsed was 9.6. Most commonly noted, 90%
of the sample felt badly about their use, 86% felt that marijuana caused

them to procrastinate or to have a lower energy level. Seventy-six percent of

the sample felt that marijuana had caused them to experience memory loss,
75% thought their marijuana use resulted in lower productivity, and 74%

thought it decreased their self-esteem. Also endorsed by the majority of
participants was the feeling that marijuana caused a lack of self-confidence

(68%), produced withdrawal symptoms (61%), and caused problems with
their partner (58%).

4.3e. Hazardous Use. The Marijuana Treatment Project examined the

assumption that marijuana has few negative consequences associated with
its use. Five hazardous use questions (Table 9) were designed to examine

the frequency of marijuana use within one hour prior to a number of
common activities in which using marijuana might put the user or others at
risk of injury. Those activities were: a) driving an automobile, b) taking care

of children, c) operating dangerous equipment, d) working on a paid job, and

e) playing sports or recreating. It is important to note that these percentages
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do not reflect the actual frequency in which the subject participated in the

activity.

Overall, 54% of the sample was under the influence of marijuana
while driving on a daily or almost daily basis, and 31% used marijuana daily
while operating other dangerous equipment. Seventeen percent of the

sample reported using marijuana before taking care of children on a daily
basis. For those employed, 40% reported smoking every day within one

hour of working on a paid job. Approximately 20% used marijuana in

conjunction with sporting or recreational activities on a daily or almost daily
basis.

4.3f. Analyses by Gender, Ethnicity,

and Employment Status. As part

of this study’s initiative, there was a special effort to specifically target

culturally and economically diverse samples including women. The following
section will look at quantity and frequency of marijuana use as well as

severity of use for these target groups. There were no significant differences
in marijuana or other drug use, as well as lifetime treatment history for drug
or alcohol abuse across gender. However, females in our sample had

significantly higher values for the Addiction Severity Index composite scores.

They experienced more psychiatric problems (. 19 Females vs.. 13 Males; t
3.21, p<.01), medical problems (.27 Females vs..21 Males; t=--2.03, p<.05},

employment problems (.27 Females vs..20 Males; t=-3.16, p<.01), and drug
problems (.26 Females vs..24 Males; t=-2.34, p<.05), than the men in our
sample. The women in our sample also scored higher on the Beck
Depression Inventory (12.74 Females vs. 10.85 Males; t=-2.38, p<.05),
indicating overall higher levels of depression than did men. Women in our
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sample spent significantly more days with a psychiatric counselor (1.09
Females vs..53 Males; t=-2.13, p<.05), and took medication for psychiatric

problems on more days (14.20 Females vs. 6.54 Males; t=-2.68, p<.01), and
medical problems on more days (21.72 Females vs. 14.20 Males; t=-2.25,

p<.05), than the men. Table 10 highlights these significant findings across

gender.
Also of note, gender was found to be associated with driving under the
influence of marijuana. 60% of the men in the sample, versus 43% of the

women (2 15.44, p<.01) reported driving daily or almost daily while high.

Significant differences across ethnicity emerged relative to marijuana
and other drug use during the 90 days prior to the baseline interview (Table

11). Though ethnic groups reported similar rates of alcohol use (i.e., days of
alcohol use), Hispanics reported significantly higher levels of consumption

(i.e., number of drinks per drinking day) than did Whites (2.50 Hispanics vs.
1.84 Whites; F=4.73, p<.01). Hispanics also used other drugs on

significantly more days than African Americans (1.78 Hispanics vs..42
African Americans; F=-3.35, p<.05). The marijuana use variables from the
Time Line Follow-Back Interview revealed some differences between ethnic

groups. Whites were high for more hours of the day than either of the other
two groups (7.04 Whites vs. 5.55 African Americans, 5.74 Hispanics; F=-4.22,

p<.05), yet Hispanics used marijuana on more days (of the 90 day time
period) than the other two groups (83.17 Hispanics vs. 79.40 Whites, 75.47
African Americans; F=4.66, p<.05).

Hispanic members of the sample reported that although they did not
begin using marijuana at an earlier age than Whites and African Americans,
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marijuana caused them problems earlier in their smoking careers (23.31
Hispanics vs. 27.46 Whites, 28.44 African Americans; F=-7.87, p<.01). The

ASI Employment composite score showed that African Americans in our

study experienced more employment problems than did either of the other
two groups (.30 African Americans vs..21 Whites, .22 Hispanics; R=-4.65,

p<.05).
With regard to past treatment experiences, differences across

ethnicity were significant for the number of days using medications for a
medical problem. Whites, on average used medications at a significantly

higher rate than Hispanics (19.51 Whites vs. 8.35 Hispanics; F=-4.55, p<.05).
Marijuana and other drug use variables, including lifetime treatment
for alcohol or other drugs did not differ significantly across employment
condition. In addition, other treatment variables including, hospitalizations,

medication use and other psychiatric treatment did not differ across groups,
with the exception of the number of days seen for medical care. Those who
were unemployed saw a medical practitioner on more days (in the past 90)

than those who worked full time (7.08 Unemployed vs. 1.79 Employed FT;

F=-3.39, p<.05). Those who were unemployed also scored higher than both

employed groups on the ASI Medical composite score (.43 Unemployed vs.
.24 Employed PT, .20 Employed FT; F=- 16.11, p<.01).

Severity measures, however, did differ between employment groups

(Table 12). Those who were unemployed scored higher than the employed
groups on the Beck Depression Inventory (15.52 Unemployed vs. 12.07

Employed PT, 10.63 Employed FT; F=-10.10, p<.01). Full time employed
individuals scored significantly lower than the other two groups on the State
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Anxiety Inventory (38.42 Employed FT vs. 42.10 Employed PT, 43.94

Unemployed; F=6.80, p<.01), the MarijuanaProblem Scale (9.23 Employed
vs. 10.57 Employed

PT, 10.48 Unemployed; F=5.84, p<.01), and the ASI

Psychiatric composite score (. 13 Employed FT vs.. 19 Employed PT, .24

Unemployed; F 12.24, p<.01). Not surprisingly, all groups differed from the
other on the ASI Employment composite score. Those unemployed scored
the most severe and those employed full time reported the fewest

employment problems (. 14 Employed FT vs..31 Employed PT vs..53
Unemployed; F 161.64, p<.01). Age of regular or problem marijuana use did
not differ between groups, and the number of dependence problems as

reported on the SCID also did not differ between the groups.

5. Summary and Discussion.

Over a decade ago, Roffman and Barnhart (1987) initiated exploration
of chronic marijuana users (i.e., who were not abusing alcohol or other

drugs), the problems associated with long-term use, and their willingness to

engage in treatment. This was the first step in examining a population of

dependent marijuana smokers. A further study indicated that not only did a
group of heavy marijuana smokers exist, but that they felt dependent on the

drug, and were looking for marijuana specific treatments to help them quit

(Stephens, Roffman, & Simpson, 1993). With the prevalence rate of current
marijuana use on the rise since the early 1990’s, and with the knowledge
that many of these individuals were interested in treatment for their

dependence, additional studies were conducted to examine treatment
efficacy (Budney et al., 1999; Stephens, Roffman, & Curtin, in press;
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Stephens, Roffman, & Simpson, 1994). Unlike previous studies of its kind,
the Marijuana Treatment Project is the largest study and the first multi-site

study to specifically target culturally and economically diverse individuals as
well as women. This paper has shown that, although previous studies have

been limited in recruiting primarily Caucasian men, MTP was effective in
attracting greater numbers of Non-Whites (31%) and females (32%).
5.1. Rationale for Marijuana-Specific Treatment. The number of callers
interested in the MTP study, indicated that there is a substantial group of

heavy marijuana users who are concerned about their use. In addition,
previous studies have shown that, if a marijuana-specific treatment program
is offered, individuals experiencing problems with their marijuana use will

be drawn to participate. Most of these individuals have not sought
treatment before. Although data pertaining to lifetime treatment episodes
were restricted to the final randomized sample, participants reported few

prior treatment episodes for drug abuse (.31). Among the reasons for this

may be due to the fact that there were virtually no marijuana-specific
treatment programs available to them. Most of the screened sample were
not co-dependent on other drugs or alcohol. In fact only 25% of the entire

screened sample was ineligible due to concurrent drug or alcohol therapy
and only 31% were excluded because of current dependence on another

drug or alcohol. These two groups were not mutually exclusive. Individuals
with primary marijuana dependence may not feel that they belong in the

same treatment program as those dependent on substances such as alcohol,

cocaine, or heroin. They may feel that their marijuana problem is not

important enough to warrant special focus, an attitude that may be
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conveyed by substance abuse facilities that view certain drugs as more
serious.

Participants screened for participation in the Marijuana Treatment
Project were about 35 years old and functioning at a relatively normal level
in society. Almost two-thirds were employed full-time and had an average

education level of 14 years despite smoking approximately 4 times a day for

many years. Demographic characteristics from the final MTP sample
indicated that unlike previous studies, this study was able to attract females
as well as minority individuals for participation in a marijuana specific

treatment program. Similar to other studies, the large majority of

participants were employed. In addition, 40% were married, and 46% lived
in their own home (or family owned home) which indicated a high level of

socio-economic stability for this group. In addition, the findings suggest
minimal levels of general psychiatric or other substance co-morbidity.

5.2. Barriers to Treatment Participation. Once individuals were

screened as potentially eligible based on the Quick Screen information, a

large percentage (45%) of them decided not to enroll in the study by
declining participation after the screening process or by not attending their
scheduled baseline interview. The results indicated that social stability, as
well as ethnic group were associated with treatment participation. In

particular, individuals who chose not to participate, were more likely to have
moved recently, be unmarried, unemployed, younger, and less educated

compared to those who did come in for treatment. This may be related to
the participants’ readiness to change, maturity, or other competing life
stressors.
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African Americans were also less likely to enter into treatment than

Hispanics or Whites. There was an effort to recruit minority research
assessors and therapists at the treatment sites. However, there were no
African American research staff at the Farmington site where most of the

African American volunteers were screened, perhaps decreasing the comfort

level needed for the initial steps to begin treatment. Treatment that is

culturally competent and sensitive has been an important and growing
concern in the area of substance abuse treatment (Copeland, 1997).

Other variables associated with the decision to participate included
individuals’ own beliefs about their marijuana dependence. Those who did

not believe that they were dependent on marijuana were less likely to

participate. Theoretically, some of these volunteers may not actually have
been dependent on marijuana. For others, perhaps there was an initial
interest in treatment, some contemplation, but ambivalence about taking
action in committing to therapy (Prochaska & DiClemente, 1983). Because

dependence on another drug or alcohol was an exclusion criterion, comorbid drug use was not a significant factor among study participants.

However, those who were heavier drinkers (i.e., more alcohol
drinks/drinking day), as well as users of sedatives or cocaine were less likely
to participate beyond the screening interview. These data suggest that

although those who chose not to participate were not necessarily dependent
on alcohol or other drugs, their substance use pattern indicated they might

be more severe or likely to be at risk of abusing other substances.

The examination of social stability, ethnic and educational barriers to

participation in treatment as well as assessment of individuals’ commitment
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or motivation to change behaviors early in the treatment process, may be an

integral part of designing programs which encourage treatment initiation
and subsequent attendance.

5.3. Consequences

of Marijuana Dependence.

Despite the fact that

MTP participants appeared to function well in society (i.e., most were
working, educated, had a stable living environment), perpetuating the myth
that marijuana is a benign drug, they experienced many problems related to
their use. The sample reported experiencing an average of 80% of the DSM-

IV dependence criteria, and nearly all participants (95%) reported that they
did not stop using despite knowing that it caused persistent or recurrent

psychological or physiological problems. Study participants reported being
high most of the day (more than six hours), and smoking almost every day of
the week. These data highlight the chronicity of the problem for individuals
who have been without the aid of prior treatment interventions. In addition,
this evidence helps to demonstrate that some individuals develop a chronic
use pattern which is connected with recurrent psychological, social and

physical problems that may be sustained by an underlying dependence

syndrome. It is likely that these individuals would function at an even
higher level in society without the problems caused by their marijuana

dependence.
Another myth is that marijuana use is not associated with hazardous
risk situations. However, data from MTP indicate that individuals, who

smoke for a large portion of every day, are likely to put themselves or others
at risk. Many subjects were under the influence of marijuana while driving,
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taking care of children, and working, despite endorsing problems associated
with cognitive functioning.

5. 4. Other Severity Indices. Though men and women were not found
to differ significantly in their marijuana use, women scored higher on many

of the Addiction Severity Indices. They reported experiencing more

psychiatric, medical, employment, and drug-related problems. In addition,

they reported higher depression scores on the BDI than did men in the
sample. However, women historically tend to report emotional and medical
problems more frequently than do men, and studies have shown that women
in general tend to have higher mean BDI scores than men (Beck, Steer, &

Garbin, 1988). It should also be noted that the mean BDI scores for both
men and women represent only mild clinical depression.

Overall, the scores for the psychiatric, medical, and drug composite
scores appear to be consistent with published ASI score means for other

drug and alcohol abusing samples. For the ASI in general, women typically
score higher on the psychiatric composite score, as these data show, but the
means for the other indices vary according to the drug of abuse. This

sample of marijuana-dependent women scored significantly higher on all of
the composite scores. One interesting note is that the Employment

composite score overall is lower for this sample than is typically seen for ASI
means

(McLellan et al., 1992). This finding is constant with the notion that

marijuana "works" (nearly 70% of the sample are employed full time).

However, that is not to say that these individuals might be more productive
if not for their chronic use.
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The ASI Employment scale scores also indicated that African
Americans in this study experienced more employment problems than did
Whites or Hispanics. These important issues may be addressed in treatment

programs that employ case management as a component of the therapy.
Other findings across ethnicity, which may be useful, include differences in

age of problem use. Though Hispanics do not tend to begin their marijuana
use career at an earlier age, they report problems attributable to their use at
an earlier age than Whites or African Americans. It may be important for

treatment outreach programs to specifically target younger Hispanics.

Although an effort was made to recruit and serve under-employed
individuals, this study initiative was met with moderate success.
Differences across employment however, were detected, particularly in the

psychiatric severity measures. For instance individuals who were employed
full time tended to be less depressed, have a lower anxiety level, and fewer

psychiatric problems than those who were employed part time, or not at all.
Again, the BDI scores fall in the high normal range. Yet, with regard to the
Anxiety Inventory, even though full time employees scored lower than the
those who were underemployed, all groups reported higher means than the

average working adult, indicating that perhaps the level of anxiety overall is
elevated for these marijuana-dependent individuals. Unemployed

participants also sought substantially more medical care than full time

employed individuals in the study, and they scored higher on the ASI
Medical composite score. The tendency for underemployed individuals to

present for treatment with a more severe medical and psychiatric profile
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than those who are employed may increase the likelihood that overcoming

dependence will be a difficult challenge for these more severe individuals.
5.5. Summary. In summary, data from the Marijuana Treatment
Project will provide information to the research and treatment community
relevant to designing marijuana-specific treatment programs and enhancing
treatment access. The demographic and clinical characteristics outlined in
this paper are consistent with previous studies in showing that there is a

group of marijuana-dependent individuals who are seeking marijuanaspecific treatment for their addiction. It is also important to note that there
are a significant number of individuals who experience barriers to treatment,

which, if addressed by providers, may increase treatment access.
The study initiative to recruit a larger, more diverse sample of chronic

marijuana users as well as women was met with good success allowing

generalizability to a more heterogeneous group. Because these data are
derived from a research study, individuals were excluded for reasons that

would not preclude them from entering a substance abuse treatment

program. Therefore, individuals with co-morbid addictions, severe
psychiatric status or court-mandated treatment should also be considered in
planning strategies to increase treatment access.
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APPENDICES
Table 1: Baseline Assessments

Assessment

Purpose

The Quick Screen

Basic demographics, inclusion and
exclusion criteria

SCID Alcohol and Drug Modules

DSM-IV criteria for alcohol and drug
abuse and dependence

Time-Line Follow Back Calendar
for Marijuana Use

Quantity & frequency of marijuana
use, and use in hazardous situations

Treatment Utilization

Utilization of medical, psychiatric,
and other social services, as well as
use of medications

Questionnaire

Severity of drug, alcohol, medical,
employment, legal, psychiatric, and
social problems based on composite
Addiction Severity Index

scores

State Trait Anxiety (Y-1)

State anxiety level

Beck Depression Inventory

Level of depression

Marijuana Problem Scale

Number of marijuana problems
endorsed
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Table 2" Demographic Characteristics From the Quick Screen,
Eligible Screened Sample

Characteristic

Gender
Male
Female
Ethnic Group
White
Hispanic
African American
Other

% of Sample
N=813

67.9
32.1

65.1
16.5
15.6
2.9

Marital Status

Married/Cohabiting
Not Married

Living Situation
Own/Family Owns
Apartment/Rent
Room/Shelter/Halfway House/No
Fixed Address
Employment Status
Full Time
Part Time
Unemployed
Stu dent / Retired / Homemaker
Characteristic

Age
Years

35.4
64.6
41.6
56.1

63.5
14.1
16.3
6.1

Mean (SD)
35.07 (8.77)

of Education

Years at Present Job

13.72 (2.11}
4.64 (5.69)
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Table 3: Alcohol and Drug Use Characteristics From the Quick Screen,
Eligible Screened Sample

Characteristic

Are you currently dependent on marijuana?
No
Yes
Don’t know
Have you ever felt dependent on alcohol?
No
Yes
Don’t know
Have you ever felt dependent on another drug?
No
Yes
Don’t know
Which substance is the biggest problem for
you now?
Marijuana
Alcohol
Other Drugs
Characteristic

Days used marijuana (of the past 90 days)
Times per day smoked marijuana

Days since last smoking episode
Alcohol drinks per drinking day
High alcohol drinking days (>5 drinks) in the
past month
Days (past 30) used sedatives
Days (past 30)used opiates
Days (past 30} used cocaine
Days (past 30) used stimulants

Days (past 30)used heroin
Days (past 30) used other drugs

% of Sample
N=813

5.8
87.1
7.2
82.4
16.4
1.3

78.2
21.6
.2

99.0
.6
.4

Mean (SD)
81.28 (14.74)
3.77 (1.67)
1.33 (3.14)
2.04 (2.06)
.93 (2.40)
.20 (1.38)

11 (.84)
.20 (1.13)
.04 (.32)
.o2 (.s3)
ii

(.88)

45
Table 4: Psychiatric Characteristics From the Quick Screen,
Eligible Screened Sample

Characteristic

Are you currently receiving treatment for a
psychiatric problem?
No
Yes
Have you ever been hospitalized for a
psychiatric problem?
No
Yes
Have you had serious thoughts of suicide in
the past 90 days?
No
Yes

% of Sample
N=813

91.7
8.3

92.5
7.5

93.7
6.3
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Table 5: Demographic Characteristics From the Quick Screen,
Significant Findings; Eligible Screened Sample by Study
Participation
% No Show
or Declined

Characteristic
Ethnic Group
White

Hispanic
African American
Other

% MTP
Participation Participant
N=450
N=363

17.72 .001
59.7
15.6
20.2
4.5

69.3
17.1
12.0
1.6

Marital Status

Married/Cohabiting
Not Married
Living Situation
Own/Family Owns
Apartment/Rent
Room / Shelter / Halfway
House/No Fixed Address
Employment Status
Full Time
Part Time
Unemployed

Sig.

10.56 .001
29.2
70.8

40.2
59.8
7.82

36.4
61.6

.020

45.8
51.8

19.30 .000
56.3
14.2
21.3

69.1
14.0
12.4

Characteristic

Mean (SD)

Mean (SD)

Age

33.78 (9.14)

36.08 (8.34)

-3.69

.000

Years of Education

13.30 (2.10)

14.04 (2.07)

-5.03

.000

Years at Present Job

4.04 (5.57)

5.03 (5.74)

-2.13

.033

.78 (1.22)

.47 (.89)

4.00

.000

Student/Retired/Homemaker

Times Moved in the Past Year

Sig.
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Table 6: Alcohol and Drug Use Characteristics From the Quick Screen,
Significant Findings; Eligible Screened Sample by Study
Participation

Characteristic

Are you currently dependent on
marijuana?
No
Yes
Don’t know

% No Show
or Declined
Participation
N=363

% MTP
Participant
N=450

2

Sig.

22.10 .000
9.7
81.4
8.9

2.7
91.6
5.8

Characteristic

Mean (SD)

Mean (SD)

Alcohol drinks per drinking day

2.29 (2.34)

1.85 (1.80)

Days (past 30) used sedatives

.33 (1.99)

Days (past 30)used cocaine

.35 (1.62)

Sig.

2.94

.003

.o9

2.20

.029

.08 (.44)

3.02

.003
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Table 7: SCID Dependence Symptoms,
Percent of MTP Participants Who Endorsed Each Symptom

Symptom Description
Tolerance: The need to smoke more
marijuana in order to get high or reach a
desired effect.
Withdrawal: The presence of marijuanaspecific withdrawal symptoms as the
result of stopping or reducing use.
Compulsion: Using for a longer period of
time than intended, or using more than
you were planning to.
Compulsion: Much time spent
buying/using/recovering from the effects
of marijuana.
Readdiction Liability: Many unsuccessful
attempts to quit or cut down.
Salience: Using takes up the time
normally spent on other important

% of Sample
N=450

68.2

77.6

76.9

83.3

96.0

activities.

64.2

Salience: Using despite persistent or
recurrent psychological or physical
problems cause by marijuana.

95.1
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Table 8: Marijuana Problem Items,
Percent of MTP Participants Who Endorsed Each Item

Item Stem
Has marijuana use caused you:
To feel bad about your use
To have lower energy level
To procrastinate
Memory loss
To have lower productivity
Lowered self-esteem
To lack self-confidence
Withdrawal symptoms
Problems between you and your partner
Financial difficulties

Difficulty sleeping
Problems in your family
To neglect your family
Medical problems
Problems between you and your friends
To miss days at work or miss classes
To lose a job
Blackouts or flashbacks
Legal problems
Total

% of Sample
N=450

90.2
86.0
86.0
76.4
75.1
74.2
68.4
61.1
58.0
48.9
46.0
44.4
38.7
33.6
26.4
19.8
8.2
7.6
7.1

Mean (SD)

Mean number of problems endorsed

(of 19)

9.59 (3.56)

5O
Table 9" Hazardous Use (in the past 90 days),
Percent of MTP Participants
Hazard StemUsed marijuana within one hour prior to...
...driving a vehicle

Never
Less than weekly
Weekly
Less than daily
Daily (or almost daily}
taking care of children
Never
Less than weekly
Weekly
Less than daily
Daily (or almost daily)
...operating dangerous equipment
Never
Less than weekly
Weekly
Less than daily
Daily (or almost daily)
...working on a paid job
Never
Less than weekly
Weekly
Less than daily
Daily (or almost daily)
...playing sports or recreating
Never
Less than weekly
Weekly
Less than daily
Daily (or almost daily)

% of Sample
N=450

12.7
8.2
11.1
13.8
54.1
66.1
8.7
4.7
3.3
17.2
39.9
12.0
9.8
7.8
30.5

33.8
12.1
7.5
6.4
40.2
30.1
16.0
22.0
12.2
19.6
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Table 10"Treatment and Medication Utilization, and Severity Measures,
Significant Findings; MTP Participants by Gender

Mean (SD)
Male Female
N=308 N=142

Variable

Psychiatc Co

osite Score (ASI)

.13

.19

(.17)

(.19)

-3.21

.001

-2.03

.043

-3.16

O

-2.34

.0

-2.38

.018

-2.13

034

-2.68

.008

.27
dicat Co

(.30)

osite Score SI)

E toyment Composite
(ASI)

ore

.24

Dmg

osite

ore (ASI)

10.85
Beck Dression

12.74

ore

Days with a counselor for

.53

(1.97)

for a

Ds on medication ar a
pbte
in the past 90 days

14.20

(30i64)

52
Table 11" Alcohol and Drug Use, Medications, and Severity Measures,
Significant Findings; MTP Participants by Ethnicity

riable

79.40

Days used ma

75.47

83.17

.010

ana

7.04

.Felt

h per day
anda alcohol dn you
d on a tical dnki
urs you

(4.89)

.42

1.78

Days used other dmgs

4.65 .010
on medications fir a

pmbte
"Others" [n=5] removed from analyses
in the past 90 days

4.55

11
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Table 12:Medical Care and Severity Measures,
Significant Findings; MTP Participants by Employment Status

--

Mean (SD)

Unem-

tie

N=311
1.79

Variable

Days seen for medical care
dical Composite Score

.20

2 27

7.08

(3.)

.24

.43

10.63

12.07

!5.52

38.42

42.10

43.94

9.23

10,57

10.48

(3.40)

(3.67)

.13

19

,24

(.18)

(.22

.31

.53

(.27)

(ASI)
ck Depression

ate A

re

ety Score

ana Problem

ychiatc Co

tment Co

ore

osite

osite

ore

re

.14

.12"24..000

Retired In=20] removed from the analyses
in the past 90 days

